Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients

AbstractIntroduction The goal of the current study was to investigate the predictive and prognostic values of repeated F-18 FDG PET/CT parameter changes for prediction of complete pathologic response (pCR) in patients with adenocarcinoma of locally advanced esophageal cancer (LAEC) who received preoperative concurrent chemoradiotherapy (PCRT).MethodsA total 53 patients with LAEC patients were included in the current study. All patients were evaluated by F-18 FDG PET/CT before and during chemoradiotherapy. The percent changes (∆, %) in F-18 FDG PET/CT parameters were used to predict pCR and to calculate overall survival (OS). The predictive value for pCR of F-18 FDG PET/CT cutoff values was determined by ROC analysis. The prognostic significance was assessed using Kaplan–Meier analysis.ResultspCR occurred in 15 patients (28.3 %). When ΔSUVmax > 23.5 % was used as cutoff, the sensitivity and specificity of F-18 FDG PET/CT for prediction of pCR were 100 % and 52.6, respectively. The AUC was 0.750 (95 % CI; 0.612–0.859), and standard error (SE) was 0.0633 (p = 0.0002). ΔMTV resulted in 80 % sensitivity, 76.3 % specificity, and 0.731 AUC (95 % CI; 0.591–0.843, SE = 0.077, p = 0.0027) for cutoff values >25.5 %. When ΔTLG > 44.8 % was used as cutoff, the sensitivity and specificity of F-18 FDG PET/CT for prediction of pCR were 100 and 65.8 %, respectively. The AUC was 0.893 (95 % CI; 0.777–0.961), and SE was 0.0431 (p < 0.0001). Kaplan–Meier analysis showed that high ΔSUVmax, ΔMTV, and ΔTLG were associated with improved OS.ConclusionIn conclusion, the current study shows the capability of the changes (Δ) in repeated F-18 FDG PET/CT parameters to predict the achievement of pCR during PCRT in LAEC patients. Among the parameters, the ΔSUVmax, ΔMTV, and ΔTLG were predictors for pCR and well associated with OS.

[1]  B. Loo,et al.  Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. , 2012, International journal of radiation oncology, biology, physics.

[2]  R. Mamidanna,et al.  Outcomes from chemoradiotherapy for patients with esophageal cancer. , 2011, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[3]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[4]  Roslyn J. Francis,et al.  Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans , 2007, Journal of Nuclear Medicine.

[5]  John L. Humm,et al.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[6]  J. Reynolds,et al.  Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the Esophagus , 2010, The Journal of Nuclear Medicine.

[7]  J. V. van Sandick,et al.  Detecting Interval Metastases and Response Assessment Using 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Esophageal Cancer , 2014, Clinical nuclear medicine.

[8]  Jin-Ching Lin,et al.  To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG‐PET/CT scan , 2015, Journal of the Chinese Medical Association : JCMA.

[9]  Andre Dekker,et al.  Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer , 2013, Acta oncologica.

[10]  J. Ajani,et al.  18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. , 2015, European journal of cancer.

[11]  P. Dupont,et al.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. M. Kwee Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review. , 2010, Radiology.

[13]  Soo Young Kim,et al.  Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. , 2007, European journal of cancer.

[14]  Kyung Soo Lee,et al.  Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications , 2010, Annals of Surgical Oncology.

[15]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[16]  J. Siewert,et al.  The importance of PET in the diagnosis and response evaluation of esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[17]  Jinming Yu,et al.  Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer. , 2011, Lung cancer.

[18]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[19]  Jae Hyuk Lee,et al.  The Predictive Role of Sequential FDG-PET/CT in Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation , 2012, American journal of clinical oncology.

[20]  W. Huang,et al.  Value of Metabolic Tumor Volume on Repeated 18F-FDG PET/CT for Early Prediction of Survival in Locally Advanced Non–Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy , 2014, The Journal of Nuclear Medicine.

[21]  M. Stuschke,et al.  Radiotherapy versus surgery within multimodality protocols for esophageal cancer--a meta-analysis of the randomized trials. , 2012, Cancer treatment reviews.

[22]  R. Boellaard,et al.  Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer , 2011, Annals of surgery.

[23]  P. Enzinger,et al.  Esophageal cancer. , 2003, The New England journal of medicine.

[24]  N. Meropol,et al.  The Role of Qualitative and Quantitative Analysis of F18-FDG Positron Emission Tomography in Predicting Pathologic Response Following Chemoradiotherapy in Patients with Esophageal Carcinoma , 2012, Journal of Gastrointestinal Cancer.

[25]  D. Rubello,et al.  Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. , 2006, AJR. American journal of roentgenology.

[26]  J. Hatazawa,et al.  Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG-PET) , 2014, Annals of Surgical Oncology.

[27]  D. Huglo,et al.  Ineffectiveness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Tumor Response After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer , 2013, Annals of surgery.

[28]  J. Takita,et al.  The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma , 2005, Cancer.

[29]  D. Rubello,et al.  The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. , 2009, International journal of radiation oncology, biology, physics.

[30]  M. Kranzfelder,et al.  Meta‐analysis of neoadjuvant treatment modalities and definitive non‐surgical therapy for oesophageal squamous cell cancer , 2011, The British journal of surgery.

[31]  N. Holalkere,et al.  Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  D. Gotley,et al.  Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[33]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[34]  Jeon Yeob Jang,et al.  Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer , 2009, Clinical Cancer Research.